Literature DB >> 3978119

A reappraisal of leukocyte dehydroascorbate reductase.

R L Stahl, L F Liebes, R Silber.   

Abstract

Dehydroascorbate reductase (glutathione:dehydroascorbate oxidoreductase, EC 1.8.5.1) activity was determined in human leukocyte homogenates using a direct spectrophotometric assay. Despite previous studies, using a less sensitive coupled assay, which reported that this enzyme was present in leukocytes, we found that neither neutrophil nor chronic lymphocytic leukemia lymphocyte extracts had detectable activity. Furthermore, when the product was quantitated by HPLC, protein-dependent generation could not be demonstrated. Mixing experiments with a partially purified enzyme preparation from spinach leaves provided no evidence for the presence of an inhibitor in neutrophil homogenates. These findings suggest that in human leukocytes, dehydroascorbate reduction does not occur enzymatically.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3978119     DOI: 10.1016/0304-4165(85)90189-8

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  4 in total

1.  Purification, cloning and expression of dehydroascorbic acid-reducing activity from human neutrophils: identification as glutaredoxin.

Authors:  J B Park; M Levine
Journal:  Biochem J       Date:  1996-05-01       Impact factor: 3.857

2.  Purification of NADPH-dependent dehydroascorbate reductase from rat liver and its identification with 3 alpha-hydroxysteroid dehydrogenase.

Authors:  B Del Bello; E Maellaro; L Sugherini; A Santucci; M Comporti; A F Casini
Journal:  Biochem J       Date:  1994-12-01       Impact factor: 3.857

3.  Purification and characterization of glutathione-dependent dehydroascorbate reductase from rat liver.

Authors:  E Maellaro; B Del Bello; L Sugherini; A Santucci; M Comporti; A F Casini
Journal:  Biochem J       Date:  1994-07-15       Impact factor: 3.857

Review 4.  Dehydroascorbate reduction.

Authors:  W W Wells; D P Xu
Journal:  J Bioenerg Biomembr       Date:  1994-08       Impact factor: 2.945

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.